Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era.
Kari Hansen BergGudrun Elin RohdeAnne PrøvenEsben Esther Pirelli BenestadMonika ØstensenGlenn HaugebergPublished in: The Journal of rheumatology (2019)
Our data suggest that inflammation in patients with axSpA even in the biologic treatment era reduces SQOL.